Oral methadone versus sublingual buprenorphine for the treatment of acute opioid withdrawal: A triple-blind, double-dummy, randomized control trial
PsiquiatriaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Drug and alcohol dependence
- Publicado em
- 12 jul 2025
- Citações
- 2
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Oral methadone versus sublingual buprenorphine for the treatment of acute opioid withdrawal: A triple-blind, double-dummy, randomized control trial
Anil Shekhawat, Atul Ambekar, Alok Agrawal, Ravindra Venkat Rao, Ashwani Kumar Mishra, Arpit Parmar, Tathagata Biswas
Descritores MeSH
- Narcotic Antagonists
- Opioid-Related Disorders
- Substance Withdrawal Syndrome
- Methadone
- Buprenorphine
- Opiate Substitution Treatment
- Female
- Humans
- Administration, Oral
- Middle Aged
Veja também
Estudos relacionados
- Differential effect of cannabis use on opioid agonist treatment outcomes: Exploratory analyses from the OPTIMA study
- Pharmacological treatment strategies to manage precipitated withdrawal following the administration of buprenorphine in opioid use disorder: A systematic review
- Low-dose Buprenorphine Initiation in Pregnancy: A Systematic Review
- Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: an updated systematic review